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Methods 
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Osteogenesis imperfecta (OI) 
Phenotype 
• Bone fragility 
• Scoliosis 
• Bone deformities 
• Short stature 
Prevalence 
• 1/10.000 
• Blue sclerae 
• Dental abnormalities 
• Hearing loss (50%) 
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Osteogenesis imperfecta (OI) 
Classification 
Type Severity Inheritance Mutated gene 
I Mild AD COL1A1/COL1A2 
II Lethal AD COL1A1/COL1A2 
III Severe AD COL1A1/COL1A2 
IV Moderate AD COL1A1/COL1A2 
V Moderate AD Unknown 
VI Moderate-severe AR SERPINF1 
VII Severe/lethal AR CRTAP 
VIII Severe/lethal AR LEPRE1 
IX Moderate to lethal AR PPIB 
X Severe to lethal AR SERPINH1 
XI Severe AR FKBP10 
I il   L / L 2 
II t l  L 2 
III   L 2 
I  t   L 2 
90 % 
5% 
AD: autosomal dominant; AR: autosomal recessive 
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Normal 
OI 
Quantitative defect 
OI  
Qualitative defect 
Genotype 
• 90%: autosomal dominant mutation in  
  COL1A1   
  COL1A2   
Type I collagen 
 
• Type I collagen synthesis: 
Mild type I • Mild type I 
• Lethal Type II 
• Severe type III 
• Moderate type IV  
• ≥ 1000 distinct mutations 
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Research aims 
• Audiologic characterization 
• Radiologic evaluation 
• Correlating the audiologic phenotype to the genotype  
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Subjects: 
• N=182 (84 Belgian, 67 Dutch, 31 Italian) 
 
• Mean age: 30.2 y. (SD:16,9; 3-89 y) 
Measurements/analyses: 
Audiometry Temporal bone 
imaging 
Genotype 
assessment 
152 
4 
26 
OI types 
Mild OI type I
Severe OI type III
Moderate OI type
IV
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1. Audiologic phenotype (1) 
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Audiologic phenotype 0-9 y.  10-19 y. 
(n=32) (n=88) 
Normal 30 (94%) 58 (66%) 
Hearing loss 2 (6%) 30 (33%) 
• Mild (20-40 dB HL) 2 (6%) 11 (12.%) 
• Moderate (40-70 dB HL) 18 (20%) 
• Severe (70-95 dB HL) 1 (1%) 
1. Audiologic phenotype (2) 
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2. Radiologic characterization 
• Computed tomography (CT) images of temporal bone 
• 17 hearing-impaired OI patients (conductive or mixed) 
Fenestral hypodensities Retrofenestral hypodensities 
Horizontal 
semicircular 
canal 
Pericochlear bone Double ring sign 
̴ air-bone gap ̴ bone conduction threshold 
Round 
window 
Fissula ante 
fenestram 
10-year old OI patient with moderate  
mixed hearing loss 
67-year old OI 
patient with  
deafness 
Oval window  
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4. Audiologic phenotype-genotype correlation in OI (1) 
• 114 OI subjects 
o Hearing-impaired (conductive/mixed/sensorineural) 
o Normal hearing and age ≥ 40 y. 
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4. Audiologic phenotype-genotype correlation in OI (2) 
SNHL 
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NL/C 
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Intrafamilial variability in audiologic phenotype 
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5. Genetic modifiers for hearing loss in OI 
• No correlation between audiologic phenotype and COL1A1/COL1A2 mutation 
• Additional genetic trigger? 
• Clinical similarities with otosclerosis 
Associated with SNP T263I in TGFB1 (protective)* 
 
Audiologic phenotype 
C allele T allele 
n (%) n (%) 
Normal hearing 18 (17.3) 0 (0.0) 
Hearing loss 86 (82.7) 5 (100.0) 
o Conductive/mixed hearing loss 70 (67.3) 3 (60.0) 
o Pure sensorineural hearing loss 16 (15.4) 2 (40.0) 
Audiologic phenotype in OI is NOT associated with SNP T263I in TGFB1  
*Thys et al. (2007) The coding polymorphism T263I in TGF-beta1 is associated with otosclerosis in two 
independent populations. Hum Mol Genet;16(17):2021-2030. 
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Audiologic phenotype in OI 
• Heterogeneous, intrafamilial variability 
• Hearing loss may develop in childhood, usually before 40y. 
• Regular follow-up recommended 
• No association with COL1A1/COL1A2 mutation 
• No association with SNP T263I in TGFB1 
Future perspectives 
• Genetic modifiers for hearing loss 
• Effect of pharmacological treatment (bisphosphonates) on hearing 
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